Clinical Response to Discordant Therapy in Third-Generation Cephalosporin-Resistant UTIs
- 1 February 2020
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 145 (2)
- https://doi.org/10.1542/peds.2019-1608
Abstract
OBJECTIVES: To describe the initial clinical response and care escalation needs for children with urinary tract infections (UTIs) resistant to third-generation cephalosporins while on discordant antibiotics. METHODS: We performed a retrospective study of children Escherichia coli or Klebsiella spp. nonsusceptible to ceftriaxone with a positive urinalysis). We included children started on discordant antibiotics who had follow-up when culture susceptibilities resulted. Outcomes were escalation of care (emergency department visit, hospital admission, or ICU transfer while on discordant therapy) and clinical response at follow-up (classified as improved or not improved). RESULTS: Of the 316 children included, 78% were girls and the median age was 2.4 years (interquartile range 0.6–6.5). Children were evaluated in the emergency department (56%) or clinic (43%), and 90% were started on a cephalosporin. A total of 7 of 316 children (2.2%; 95% confidence interval 0.8%–4.5%) experienced escalation of care. For the 230 children (73%) with clinical response recorded, 192 of 230 (83.5%; 95% confidence interval 78.0%–88.0%) experienced clinical improvement. In children with repeat urine testing while on discordant therapy, pyuria improved or resolved in 16 of 19 (84%) and urine cultures sterilized in 11 of 17 (65%). CONCLUSIONS: Most children with third-generation cephalosporin-resistant UTIs started on discordant antibiotics experienced initial clinical improvement, and few required escalation of care. Our findings suggest that narrow-spectrum empiric therapy is appropriate while awaiting final urine culture results.This publication has 32 references indexed in Scilit:
- Treatment Of Pyelonephritis Caused By Extended-Spectrum Β-Lactamase–Producing Enterobacteriaceae in ChildrenThe Pediatric Infectious Disease Journal, 2013
- Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 MonthsPEDIATRICS, 2011
- Second-dose Varicella Vaccination Coverage in Children and Adolescents in a Managed Care Organization in California, 2006–2009The Pediatric Infectious Disease Journal, 2011
- Outcome of Urinary Tract Infections Caused by Extended Spectrum β-Lactamase-producing Enterobacteriaceae in ChildrenThe Pediatric Infectious Disease Journal, 2011
- Febrile Urinary Tract Infections in ChildrenThe New England Journal of Medicine, 2011
- Febrile Infants With Urinary Tract Infections at Very Low Risk for Adverse Events and BacteremiaPEDIATRICS, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Setting and Revising Antibacterial Susceptibility BreakpointsClinical Microbiology Reviews, 2007
- Susceptibility of Recent Bacterial Isolates to Cefdinir and Selected Antibiotics among Children with Urinary Tract InfectionsAcademic Emergency Medicine, 2006
- Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitisThe American Journal of Medicine, 1951